Filing Details

Accession Number:
0001127602-16-054799
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-06 13:45:33
Reporting Period:
2016-06-03
Filing Date:
2016-06-06
Accepted Time:
2016-06-06 13:45:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816956 Conmed Corp CNMD Electromedical & Electrotherapeutic Apparatus (3845) 160977505
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238337 A Luke Pomilio C/O Conmed Corp
525 French Road
Utica NY 13502-5994
Evp, Finance & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-06-03 10,000 $29.92 41,884 No 4 M Direct
Common Stock Disposition 2016-06-03 4,400 $41.56 37,484 No 4 S Direct
Common Stock Acquisiton 2016-06-03 10,000 $26.69 47,484 No 4 M Direct
Common Stock Disposition 2016-06-03 1,794 $41.83 45,690 No 4 F Direct
Common Stock Disposition 2016-06-03 2,280 $41.83 43,410 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Sars (Stock Appreciation Rights) Disposition 2016-06-03 10,000 $0.00 10,000 $29.92
Common Stock Sars (Stock Appreciation Rights) Disposition 2016-06-03 10,000 $0.00 10,000 $26.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2008-05-17 2017-05-17 No 4 M Direct
0 2009-06-01 2018-06-01 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.53 to $41.62. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder."
  2. The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period.